tldrgov

Public Health & Environment Committee

Wednesday, September 17, 2025 · 10:00 AM AM · Virtual/Du Burns Council Chamber, 4th floor, City Hall, Phone: 1-408-418-9388, Access code: 2349 848 6984, Password: Public Link: https://bmore.webex.com/bmore/j.php?MTID=m1e7aa440bda0bab5b55e14c69d9aa349

TL;DR

The City Council held an informational hearing about placing Naloxone (an overdose reversal drug) in public buildings across Baltimore, as required by a new state law. City officials were asked to present their current readiness and plans to update health and safety protocols in all City buildings.

Key Decisions

  • Naloxone Availability Assessment Hearing Called to Recess - Pending Further Review
Agenda PDF Minutes PDF

Agenda

  1. INTRODUCTIONS
  2. ATTENDANCE
  3. ITEM SCHEDULED FOR PUBLIC HEARING
  4. 25-0005R Informational Hearing - Availability of Naloxone in Public Buildings FOR the purpose of requiring the City Administrator, Commissioner of the Baltimore Health Department, and the Director of the Department of General Services to appear before the City Council to present an assessment of the City’s readiness to comply with the provisions of Chapter 764 of the Acts of the Maryland General Assembly of 2024, “Emergency Services – Automated External Defibrillator and Naloxone Co-Location Initiative – Requirements for Public Buildings”, by updating its health and safety protocols for all City buildings.
    City Council Resolution

    Hearing called to recess.

  5. ADJOURNMENT
  6. THIS MEETING IS OPEN TO THE PUBLIC